Literature DB >> 2172542

Molecular interactions of cytomegalovirus and the human and simian immunodeficiency viruses.

P A Barry1, E Pratt-Lowe, R E Unger, M Marthas, D J Alcendor, P A Luciw.   

Abstract

In HuT 78 cells chronically infected with SIV, super-infection with rhesus cytomegalovirus (rhCMV) stimulated an increase in SIV replication. Utilizing transient expression assays with the SIV long terminal repeat (LTR) driving expression of the chloramphenicol acetyltransferase (CAT) reporter gene, the increase in SIV replication, by coinfection with CMV, was due to transactivation of the SIV LTR by the immediate early gene products (IE) of rhesus CMV. Similarly, IE of human CMV stimulated expression from both the SIV and HIV LTRs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172542

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  4 in total

1.  Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.

Authors:  A Kaur; M D Daniel; D Hempel; D Lee-Parritz; M S Hirsch; R P Johnson
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1.

Authors:  A Mergia; E Pratt-Lowe; K E Shaw; L W Renshaw-Gegg; P A Luciw
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Cellular factors regulate transactivation of human immunodeficiency virus type 1.

Authors:  P A Barry; E Pratt-Lowe; R E Unger; P A Luciw
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Association Between Cytomegalovirus and Epstein-Barr Virus Viremia And Human Immunodeficiency Virus DNA Levels in the Reservoir of Kenyan Infants Receiving Antiretroviral Therapy.

Authors:  Jennifer A Slyker; Brandon Guthrie; Mark Pankau; Kenneth Tapia; Dalton Wamalwa; Sarah Benki-Nugent; Evelyn Ngugi; Meei-Li Huang; Irene Njuguna; Agnes Langat; Grace John-Stewart; Dara Lehman
Journal:  J Infect Dis       Date:  2021-06-04       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.